PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Stock Information for Pharmadrug Inc.

Loading

Please wait while we load your information from QuoteMedia.